|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200709161
Carreno et al.
• Figure S1 Reduction of moesin activity led to mild cytokinesis defects in vivo and in S2 cultured cells.
• Figure S2 Quantification of the mitotic defects observed in S2 cells after moesin depletion and other treatments.
• Video 1 Histone-GFP in dividing control S2 cells observed by phase contrast and epifluorescence
• Video 2 Histone-GFP in dividing moesin–depleted S2 cells (6 d of dsRNA treatment) observed by phase contrast and epifluorescence
• Video 3 Sqh-GFP in dividing control S2 cells
• Video 4 Sqh-GFP in dividing moesin–depleted S2 cells (6 d of dsRNA treatment)
• Video 5 Tubulin-GFP in Slik-depleted S2 cells (6 d of dsRNA treatment)
• Video 6 Tubulin-GFP in control S2 cells
• Video 7 Tubulin-GFP in moesin-depleted S2 cells (6 d of dsRNA treatment)
• Video 8 Tubulin-GFP in moesin + RhoA double-depleted S2 cells (moesin, 6 d of dsRNA treatment; RhoA, 3 d of dsRNA treatment)
| ||||||||||||||||||||||||||
|
|
